rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG) Peptide
ARHGDIG
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Quick Overview for rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG) Peptide (ABIN937278)
Target
ARHGDIG
(rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- DEAVPEYRAP GRKSLLEIRQ LDPDDRSLAK YKRVLLGPLP PAVDPSLPN
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ARHGDIG antibody,
Alternative Names: ARHGDIG control peptide, ARHGDIG antibody Blocking Peptide, Anti-ARHGDIG Blocking Peptide, Rho Gdp Dissociation Inhibitor Blocking Peptide, Gdi Gamma Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- ARHGDIG (rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG))
-
Background
- ARHGDIG is highly expressed in the entire brain, with regional variations. The mRNA is also present at high levels in kidney and pancreas and at moderate levels in spinal cord, stomach, and pituitary gland. ARHGDIG is mapped to chromosome band 16p13.3 which is rich in deletion mutants of genes involved in several human diseases, notably polycystic kidney disease, alpha-thalassemia, tuberous sclerosis, mental retardation, and cancer.
-
Molecular Weight
- 25 kDa
Target
-
You are here:
